Post written by Natalie Wilson, MD, from the Department of Internal Medicine, University of Minnesota Medical Center, and Mohammad Bilal, MD, from the Division of Gastroenterology and Hepatology, University of Minnesota Medical Center, and Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota, USA. In this case, we describe the successful resection of a 15-mm partially healed …
Tag: dysplasia
Circumferential ESD for the treatment of ultra-short-segment Barrett’s adenocarcinoma with multifocal dysplasia
Post written by Fabian Emura, MD, PhD, FASGE, from the Division of Gastroenterology, Universidad de La Sabana, Chía, and the Advanced GI Endoscopy, EmuraCenter LatinoAmerica, Bogotá DC, Colombia. The procedure initiated from the esophagus in direct view and continued from the stomach in the retroflexion view using the IT-Knife2. A small perforation occurred when the …
Risk of progression in Barrett’s esophagus indefinite for dysplasia
Post written by Rajesh Krishnamoorthi, MD, from the Digestive Diseases Institute, Virginia Mason Medical Center, Seattle, Washington, USA. The current study is systematic review and meta-analysis to estimate the risk of progression to high-grade dysplasia and/or esophageal adenocarcinoma in patients with Barrett's esophagus indefinite for dysplasia. Barrett’s esophagus (BE) is a precursor lesion for esophageal …
Continue reading Risk of progression in Barrett’s esophagus indefinite for dysplasia
Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett’s esophagus
Post written by Madhav Desai, MD, MPH, from the Gastroenterology and Hepatology, University of Kansas Medical Center, Kansas City, Kansas, USA. Barrett’s esophagus (BE) is a known precursor lesion for esophageal adenocarcinoma (EAC), and we know that incidence of the latter is rising in last 30 years thereby necessitating early detection and management of this …
HMGA2 protein as a biomarker of dysplasia in IPMN
Christopher J. DiMaio, MD, FASGE, from the Icahn School of Medicine at Mount Sinai, Mount Sinai Medical Center, in New York, New York, USA discusses his article "Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm." No reliable cyst fluid biomarkers exist that …
Continue reading HMGA2 protein as a biomarker of dysplasia in IPMN
Salvage cryotherapy after failed radiofrequency ablation
Neil Sengupta, MD, from the Department of Medicine and Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, in Boston, Massachusetts, USA describes this Original Article, "Salvage cryotherapy after failed radiofrequency ablation for Barrett’s esophagus–related dysplasia is safe and effective." Radiofrequency ablation (RFA) is an effective and durable treatment option for patients with …
Continue reading Salvage cryotherapy after failed radiofrequency ablation
Editor’s Choice- Consensus statement on dysplasia in IBD
Associate Editor Dr. Seth Gross highlights this article “SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease” by Loren Laine, MD, Tonya Kaltenbach, MD, Alan Barkun, MD, Kenneth R. McQuaid, MD, Venkataraman Subramanian, MD, and Roy Soetikno, MD for the SCENIC Guideline Development Panel as March’s Editor’s Choice. The article …
Continue reading Editor’s Choice- Consensus statement on dysplasia in IBD
Editor’s Choice: Detection and staging of esophageal cancers within BE
Associate Editor Jacques Devière, MD, PhD recommends this Original Article from the December issue "Detection and staging of esophageal cancers within Barrett’s esophagus is improved by assessment in specialized Barrett’s units." The authors clearly address a common problem in the assessment of patients having Barrett's esophagus (BE) and dysplasia. In 2014, evaluation of these patients includes …
Continue reading Editor’s Choice: Detection and staging of esophageal cancers within BE
Sessile serrated adenomas/polyps with cytologic dysplasia
Authors Dr. Nicholas Burgess and Dr. Michael Bourke from Westmead Hospital and the University of Sydney in Sydney, NSW, Australia discuss their Thinking Outside the Box article "Sessile serrated adenomas/polyps with cytologic dysplasia: a triple threat for interval cancer" from the August issue. Sessile serrated adenoma/polyps (SSA/P) are now recognized to play an important role …
Continue reading Sessile serrated adenomas/polyps with cytologic dysplasia
Editor’s Choice- Cost-effectiveness of endoscopic surveillance
Robert Enns, MD recommends this original article from the February issue "Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett’s esophagus" by Louisa G. Gordon, PhD, George C. Mayne, PhD, Nicholas G. Hirst, MHealthEcon, Timothy Bright, MBBS, PhD, David C. Whiteman, MBBS, PhD, for the Australian Cancer Study Clinical Follow-Up Study, and David I. Watson, MBBS, PhD. …
Continue reading Editor’s Choice- Cost-effectiveness of endoscopic surveillance
endoscopedia.com 